Veracyte, Inc. (VCYT)
42.84
+0.62
(+1.47%)
USD |
NASDAQ |
Dec 12, 16:00
42.88
+0.04
(+0.08%)
After-Hours: 20:00
Veracyte Research and Development Expense (Quarterly): 15.54M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 346.00M |
| FONAR Corp. | 0.44M |
| XWELL, Inc. | -- |
| ProPhase Labs, Inc. | 0.006M |
| Insight Molecular Diagnostics, Inc. | 3.55M |